Literature DB >> 1993022

Endophthalmitis therapy: changing antibiotic sensitivity patterns and current therapeutic recommendations.

H W Flynn, J S Pulido, S C Pflugfelder, J L Davis, W W Culbertson, T J Roussel, D Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1993022     DOI： 10.1001/archopht.1991.01080020021012

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  5 in total

Review 1.  Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.

Authors:  G A Stern
Journal:  Trans Am Ophthalmol Soc       Date:  1993

2.  Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis.

Authors:  I M Gan; J T van Dissel; W H Beekhuis; W Swart; J C van Meurs
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

3.  Evaluation of potential retinal toxicity of adalimumab (Humira).

Authors:  Miltiadis Tsilimbaris; Vasilios F Diakonis; Irini Naoumidi; Spyridon Charisis; Iraklis Kritikos; George Chatzithanasis; Thekla Papadaki; Sotiris Plainis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-19       Impact factor: 3.117

4.  Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.

Authors:  T A Meredith
Journal:  Trans Am Ophthalmol Soc       Date:  1993

5.  A prospective multicenter randomized placebo-controlled trial of dexamethasone as an adjuvant in the treatment of postoperative bacterial endophthalmitis: interim safety analysis of the study drug and analysis of overall treatment results.

Authors:  Eric W Lindstedt; Carlien A Bennebroek; Dymph J van der Werf; Marc Veckeneer; Annette Ossewaarde-van Norel; Chris C Mayland Nielsen; Rene J Wubbels; Jaap T van Dissel; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-10       Impact factor: 3.117
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.